MGX
NASDAQ
US
Metagenomi Therapeutics, Inc. - Common Stock
$1.35
▲ +$0.01
(+0.75%)
Vol 83K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$60.8M
ROE
-43.2%
Margin
-287.1%
D/E
0.00
Beta
1.39
52W
$1–$4
Wall Street Consensus
9 analysts · Apr 20262
Strong Buy
5
Buy
2
Hold
0
Sell
0
Strong Sell
77.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 75.0%
Next Report
May 08, 2026
EPS Estimate: $-0.53
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.53 | — | — |
| Dec 2025 | $-0.61 | $-0.60 | +$0.01 |
| Sep 2025 | $-0.59 | $-0.55 | +$0.04 |
| Jun 2025 | $-0.63 | $-0.54 | +$0.09 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -38.8% | -38.8% | -38.8% | -38.8% | -43.2% | -43.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -233.8% | -258.0% | -258.0% | -258.0% | -287.1% | -287.1% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.36 | 6.36 | 6.36 | 6.36 | 6.42 | 6.42 |
Key Ratios
ROA (TTM)
-31.1%
P/S (TTM)
1.97
P/B
0.6
EPS (TTM)
$-2.39
Rev Growth 3Y
+499.3%
52W High
$4.29
52W Low
$1.23
$1.23
52-Week Range
$4.29
How does MGX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
MGX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
2.0
▼
85%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.6
▼
77%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
MGX profitability vs Biotechnology peers
ROE
-43.2%
▲
36%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-287.1%
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-31.1%
▲
34%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
MGX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.4
▲
45%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
1.4
▲
44%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
MGX fundamentals radar
MGX
Peer median
Industry
MGX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio